A carregar...

Population pharmacokinetics and the pharmacokinetic/pharmacodynamic relationship of riociguat in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension

Abstract. This analysis aimed to characterize the pharmacokinetics (PK) and PK/pharmacodynamic (PK/PD) relationship of riociguat and its metabolite M1 in patients with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH). Blood samples were collected in two...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pulm Circ
Main Authors: Saleh, Soundos, Becker, Corina, Frey, Reiner, Mück, Wolfgang
Formato: Artigo
Idioma:Inglês
Publicado em: University of Chicago Press 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4860535/
https://ncbi.nlm.nih.gov/pubmed/27162632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/685404
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!